FC-2.15, a monoclonal antibody active against human breast cancer, specifically recognizes Lewis(x) hapten

Keyphrases

• Monoclonal Antibody 100%
• Human Breast Cancer 100%
• Hapten 100%
• Lewis x 100%
• Neutrophil Granulocytes 75%
• MCF-7 Cells 50%
• T84 Cells 50%
• Cell-to-cell 25%
• Leukemic Cells 25%
• Chronic Myeloid Leukemia 25%
• Phase I Trial 25%
• Neutropenia 25%
• Breast 25%
• Breast Carcinoma 25%
• Colon 25%
• Glycoprotein 25%
• Lysis 25%
• Colon Adenocarcinoma 25%
• Anti-tumor Response 25%
• Neuraminidase 25%
• Human Carcinoma 25%
• Carbohydrate Moieties 25%
• Gangliosides 25%
• Hodgkin Lymphoma 25%
• Trisaccharide 25%
• Blood Group Antigens 25%
• Myeloid Leukemia Cells 25%
• Sialyl Lewis X 25%
• Cell Carcinoma 25%
• Protein Core 25%
• N-linked 25%
• Human Complement 25%
• Lewis Y 25%
• Epitope Specificity 25%
• Globo H 25%
• O-linked 25%
• Work Analysis 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Monoclonal Antibody 100%
• Breast Cancer 100%
• Hapten 100%
• Chronic Myeloid Leukemia 50%
• Clinical Trial 50%
• Neutropenia 50%
• Colon Carcinoma 50%
• Carcinoma 50%
• Breast Carcinoma 50%
• Blood Group A Antigen 50%
• Hodgkin Disease 50%
• Glycoprotein 50%
• Sialidase 50%
• Myeloid Leukemia 50%
• Trisaccharide 50%
• Blood Group B Antigen 50%
• Epitope 50%
• Core Protein 50%
• Immunoglobulin M 50%
• Carbohydrate 50%
• Ganglioside 50%
• Sialyl Lewis X Antigen 50%

Immunology and Microbiology

• Monoclonal Antibody 100%
• Myeloid 100%
• Neutrophil Granulocyte 100%
• Hapten 100%
• Colon 66%
• Epitope 33%
• Leukemia Cell 33%
• Glycoprotein 33%
• Blood Group A Antigen 33%
• Blood Group B Antigen 33%
• Immunoglobulin M 33%
• Sialyl Lewis X Antigen 33%
• In Vitro 33%
• Ganglioside 33%